提升磁共振加速器治疗效率:容积旋转调强放疗用于前列腺立体定向体部放疗的综合评估
本研究对10例曾于1.5T磁共振加速器治疗的前列腺癌患者进行回顾性再计划,比较步进式调强放疗与两种容积旋转调强放疗方案的优化与执行效率及计划质量,并评估每日磁共振影像自适应流程。结果显示容积旋转调强放疗可缩短总治疗时间并维持等效计划质量与剂量学精度。
要点
- 容积旋转调强放疗较临床步进式调强放疗缩短总治疗时间,计划质量等效。
- 所有容积旋转调强放疗计划γ通过率均大于96%,执行效率为89.7±2.7%。
- 膀胱与直肠剂量体积直方图各点组间差异在1.3%或0.8 cc以内。
核心结论
- 将容积旋转调强放疗纳入磁共振影像引导自适应放疗可显著缩短治疗时间,同时维持等效计划质量。
研究设计与样本
- 回顾性再计划研究,纳入10例曾于1.5T磁共振加速器治疗的前列腺癌患者,处方剂量36.25 Gy分5次。
- 比较步进式调强放疗(临床Hyperion优化器,Hyp-IMRT)、同一优化器的容积旋转调强放疗(Hyp-VMAT)及研究型优化器的容积旋转调强放疗(OFL+PGD-VMAT)。
- 采用「优化权重」与「优化形状」两种策略将计划适配至每日磁共振影像数据以评估适应位置工作流程。
- 通过优化时间、执行时间与总时间评估治疗效率,通过危及器官保护评估计划质量,并用修改的加速器控制系统以γ分析(2%/2 mm)评估执行精度。
主要发现
- Hyp-VMAT组较临床Hyp-IMRT组总时间减少124±140秒(P=.020),OFL+PGD-VMAT组减少459±110秒(P<.001)。
- 适应位置流程中,VMAT-Weights组较临床IMRT-Shapes组总时间减少404±55秒(P<.001)。
- 各组膀胱与直肠剂量体积直方图各点差异在1.3%或0.8 cc以内。
- 所有容积旋转调强放疗计划γ通过率均大于96%。
- 容积旋转调强放疗计划执行效率为89.7±2.7%,临床调强放疗为50.0±2.2%。
关键数值与推荐
- 处方剂量36.25 Gy分5次。
- γ分析标准为2%/2 mm。
- 执行效率计算为平均剂量率除以最大剂量率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Long treatment sessions are a limitation within magnetic resonance imaging guided adaptive radiation therapy (MRIgART). This work aims for significantly enhancing the delivery efficiency on the magnetic resonance linear accelerator (MR-linac) by introducing dedicated optimization and delivery techniques for volumetric modulated arc therapy (VMAT). VMAT plan and delivery quality during MRIgART is compared with step-and-shoot intensity-modulated radiation therapy (IMRT) for prostate stereotactic body radiation therapy. METHODS AND MATERIALS: Ten patients with prostate cancer previously treated on a 1.5T MR-linac were retrospectively replanned to 36.25 Gy in 5 fractions using step-and-shoot IMRT and the clinical Hyperion optimizer within Monaco (Hyp-IMRT), the same optimizer with a VMAT technique (Hyp-VMAT), and a research-based optimizer called optimal fluence levels and pseudo gradient descent with VMAT (OFL+PGD-VMAT). The plans were then adapted onto each daily magnetic resonance imaging data set using 2 different optimization strategies to evaluate the adapt-to-position workflow: "optimize weights" (IMRT-Weights and VMAT-Weights) and "optimize shapes" (IMRT-Shapes and VMAT-Shapes). Treatment efficiency was evaluated by measuring optimization time, delivery time, and total time (optimization+delivery). Plan quality was assessed by evaluating organ at risk sparing. Ten patient plans were measured using a modified linac control system to assess delivery accuracy via a gamma analysis (2%/2 mm). Delivery efficiency was calculated as average dose rate divided by maximum dose rate. RESULTS: For Hyp-VMAT and OFL+PGD-VMAT, the total time was reduced by 124 ± 140 seconds (P = .020) and 459 ± 110 seconds (P < .001), respectively, as compared with the clinical Hyp-IMRT group. Speed enhancements were also measured for adapt-to-position with reductions in total time of 404 ± 55 (P < .001) for VMAT-Weights as compared with the clinical IMRT-Shapes group. Bladder and rectum dosimetric volume histogram (DVH) points were within 1.3% or 0.8 cc for each group. All VMAT plans had gamma passing rates greater than 96%. The delivery efficiency of VMAT plans was 89.7 ± 2.7 % compared with 50.0 ± 2.2 % for clinical IMRT. CONCLUSIONS: Incorporating VMAT into MRIgART will significantly reduce treatment session times while maintaining equivalent plan quality.
引用
- Snyder JE, Fast MF, Uijtewaal P, et al. Enhancing Delivery Efficiency on the Magnetic Resonance-Linac: A Comprehensive Evaluation of Prostate Stereotactic Body Radiation Therapy Using Volumetric Modulated Arc Therapy. Int J Radiat Oncol Biol Phys. 2024. PMID: 39490905. doi:10.1016/j.ijrobp.2024.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。